Printer Friendly

Agfa HealthCare to introduce latest version of IMPAX for Nuclear Medicine.

M2 PHARMA-October 10, 2011-Agfa HealthCare to introduce latest version of IMPAX for Nuclear Medicine(C)2011 M2 COMMUNICATIONS

10 October 2011 - Agfa HealthCare, the diagnostic imaging and healthcare IT solutions unit of Belgian imaging company Agfa-Gevaert NV (EBR:AGFB), said today that it will introduce the latest version of its IMPAX for Nuclear Medicine solution at the 2011 Congress of the European Association of Nuclear Medicine (EANM) in Birmingham, UK, 15-19 October 2011.

The solution supports the patient's entire exam flow. It includes specialised functionalities to process, read and report all nuclear medicine, SPECT, PET, and multi-modality images with just the click of a button, from a single workstation. Images and diagnoses can be shared with referring physicians within or outside the hospital walls.

IMPAX for Nuclear Medicine consolidates images and data across a wide range of modalities and departments, integrating them into a single IT platform. It delivers increased efficiency to the nuclear medicine department, handling complex scheduling requirements, including comprehensive resource planning and scheduling across multiple departments. It can be integrated with the department's hot lab management solution to digitise and automate preparation of radiopharmaceuticals and registration of radiation dose.

IMPAX for Nuclear Medicine includes Oasis for IMPAX, developed in collaboration with Segami Corp, which brings an integrated, fully featured nuclear medicine image processing and viewing package to the IMPAX workstation. Clinicians no longer have to switch between workstations, or manually synchronise patient study lists.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Oct 10, 2011
Words:248
Previous Article:Align Technology launches Invisalign G4.
Next Article:Ligand inks Fablyn licensing agreement with Chiva Pharmaceuticals.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters